Cytosorbents shares are trading lower after the company announced an analysis by the independent DSMB on the STAR-T trial showed the study did not meet the primary effectiveness endpoint in the overall patient population.

CytoSorbents Corporation -3.63%

CytoSorbents Corporation

CTSO

0.87

-3.63%

Cytosorbents shares are trading lower after the company announced an analysis by the independent DSMB on the STAR-T trial showed the study did not meet the primary effectiveness endpoint in the overall patient population.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via